Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 3.38% vs 25.16% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is -32.75% vs 48.20% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -38.34% vs 62.01% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
Compare Quarterly Results Of JiangXi Tianxin Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -10.40% vs 42.96% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 3.38% vs 25.16% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 11.96% vs 25.89% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -32.75% vs 48.20% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -9.50% vs 16.73% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -38.34% vs 62.01% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 266.67% vs 80.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






